Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line

Hogaboam, 1998, Dynamic interactions between lung fibroblasts and leukocytes: implications for fibrotic lung disease, Proc. Assoc. Am. Physicians, 110, 313

Smith, 1995, A role for C–C chemokines in fibrotic lung disease, J. Leukoc. Biol., 57, 782, 10.1002/jlb.57.5.782

Tobler, 1992, Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of MCSF in human fibroblasts, Blood, 79, 45, 10.1182/blood.V79.1.45.45

Matsushima, 1988, Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor, J. Exp. Med., 167, 1883, 10.1084/jem.167.6.1883

Larsen, 1989, Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor, Immunology, 68, 31

Miyamasu, 1995, Chemotactic agonists induce cytokine generation in eosinophils, J. Immunol., 154, 1339, 10.4049/jimmunol.154.3.1339

Sonoda, 1997, Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-kappaB activation, J. Biol. Chem., 272, 15366, 10.1074/jbc.272.24.15366

Miyamasu, 1998, Glucocorticoids inhibit chemokine generation by human eosinophils, J. Allergy Clin. Immunol., 101, 75, 10.1016/S0091-6749(98)70196-4

Jose, 1994, Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation, J. Exp. Med., 179, 881, 10.1084/jem.179.3.881

Kitaura, 1996, Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3, J. Biol. Chem., 271, 7725, 10.1074/jbc.271.13.7725

Teran, 1999, Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts, Am. J. Respir. Cell. Mol. Biol., 20, 777, 10.1165/ajrcmb.20.4.3508

Sato, 2001, Inflammatory cytokines modulate eotaxin release by human lung fibroblast cell line, Exp. Lung. Res., 27, 173, 10.1080/019021401750069401

Miyamasu, 1999, Dermal fibroblasts represent a potent major source of human eotaxin: in vitro production and cytokine-mediated regulation, Cytokine, 11, 751, 10.1006/cyto.1999.0487

Lilly, 1997, Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids, J. Clin. Invest., 99, 1767, 10.1172/JCI119341

Komiya, 2003, Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells, Cell. Immunol., 225, 91, 10.1016/j.cellimm.2003.10.001

Suzuki, 1983, Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis. Double-blind trial, Asian Med. J., 26, 423

Arase, 1997, The long term efficacy of glycyrrhizin in chronic hepatitis C patients, Cancer, 79, 1494, 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B

van Rossum, 1999, Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial, J. Gastroenterol. Hepatol., 14, 1093, 10.1046/j.1440-1746.1999.02008.x

van Rossum, 2001, Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C, Am. J. Gastroenterol., 96, 2432, 10.1016/S0002-9270(01)02612-0

Abe, 1982, Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice, Microbiol. Immunol., 26, 535, 10.1111/j.1348-0421.1982.tb00207.x

Zhang, 1993, Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes, Immunology, 79, 528

Dai, 2001, Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages, Immunology, 103, 235, 10.1046/j.1365-2567.2001.01224.x

Abe, 2003, Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis, J. Gastroenterol., 38, 962, 10.1007/s00535-003-1179-7

Miyaji, 2002, Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of glycyrrhizin, Int. Immunopharmacol., 2, 1079, 10.1016/S1567-5769(02)00033-4

Shibata, 2000, A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice, Yakugaku Zasshi, 120, 849, 10.1248/yakushi1947.120.10_849

Hirabayashi, 1991, Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro, Chem. Pharm. Bull. (Tokyo), 39, 112, 10.1248/cpb.39.112

Kimura, 2001, Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors, Eur. J. Pharmacol., 431, 151, 10.1016/S0014-2999(01)01424-8

Shimoyama, 2003, Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats, J. Pharm. Pharmacol., 55, 811, 10.1211/002235703765951429

Cinatl, 2003, Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus, Lancet, 361, 2045, 10.1016/S0140-6736(03)13615-X

Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin. Exp. Immunol., 136, 95, 10.1111/j.1365-2249.2004.02415.x

Chibana, 2003, Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin, J. Immunol., 170, 4290, 10.4049/jimmunol.170.8.4290

Kitagawa, 1993, Saponin and sapogenol: XLVII. On the constituents of the roots of Glycyrrhiza uralensis Fischer from northeastern China: (1). Licorice-saponins A3, B2, and C2, Chem. Pharm. Bull. (Tokyo), 41, 43, 10.1248/cpb.41.43

Ko, 1992, A sensitive enzyme-linked immunosorbent assay for human interleukin-8, J. Immunol. Methods, 149, 227, 10.1016/0022-1759(92)90254-Q

Wada, 1999, Eotaxin contributes to renal interstitial eosinophilia, Nephrol. Dial. Transplant., 14, 76, 10.1093/ndt/14.1.76

Kobayashi, 2002, Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma, Anticancer Res., 22, 4053

Sasaki, 2002, Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients, Pathobiology, 70, 229, 10.1159/000069334

Pompei, 1979, Glycyrrhizic acid inhibits virus growth and inactivates virus particles, Nature, 281, 689, 10.1038/281689a0

Ito, 1987, Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)], Antiviral Res., 7, 127, 10.1016/0166-3542(87)90001-5

Numazaki, 1994, Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus, J. Leukoc. Biol., 55, 24, 10.1002/jlb.55.1.24

Utsunomiya, 1997, Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus, Antimicrob. Agents Chemother., 41, 551, 10.1128/AAC.41.3.551

Murayama, 1994, Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8, J. Virol., 68, 7582, 10.1128/JVI.68.11.7582-7585.1994

Balbi, 2000, Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation?, Chest, 117, 1633, 10.1378/chest.117.6.1633

Gonzalo, 1996, Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors, J. Clin. Invest., 98, 2332, 10.1172/JCI119045

Lamkhioued, 1997, Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation, J. Immunol., 159, 4593, 10.4049/jimmunol.159.9.4593